Storia in 3 fonti

Dr Reddy's delays Semaglutide supplies after API-related quality issue

Dr Reddy's delayed Semaglutide supplies after certain batches failed quality specifications due to an API issue. The company said patient safety is unaffected.

Raccontata da

economictimes.indiatimes.com

thehindubusinessline.com

thehindu.com

Confronto fonti

3 prospettive sulla stessa storia

AI · summaries

thehindubusinessline.comStai leggendo1 mese fa

Dr Reddy's delays Semaglutide supplies after API-related quality issue

Dr Reddy's delayed Semaglutide supplies after certain batches failed quality specifications due to an API issue. The company said patient safety is unaffected.

originale

economictimes.indiatimes.com1 mese fa

Dr Reddy's flags quality issue in semaglutide batches, delays commercial supplies

Dr Reddy's Laboratories has announced a setback in the distribution of their semaglutide products attributed to out-of-specification batches associated with an active ingredient concern. The firm is actively…

Leggi questa versione →

Timeline cronologica

giovedì 9 luglio 2026·economictimes.indiatimes.com
Dr Reddy's flags quality issue in semaglutide batches, delays commercial supplies
Dr Reddy's Laboratories has announced a setback in the distribution of their semaglutide products attributed to out-of-specification batches associated with an active ingredient…
giovedì 9 luglio 2026·thehindubusinessline.com
Dr Reddy's delays semaglutide supply due to active ingredient issue
Dr. Reddy's delays semaglutide supply due to ingredient issues, impacting shares but posing no safety risks.

Dr Reddy's delays Semaglutide supplies after API-related quality issue

Confronto fonti

Dr Reddy's delays Semaglutide supplies after API-related quality issue

Dr Reddy's flags quality issue in semaglutide batches, delays commercial supplies

Timeline cronologica

Dr Reddy's flags quality issue in semaglutide batches, delays commercial supplies

Dr Reddy's delays semaglutide supply due to active ingredient issue

Dr. Reddy’s to delay semaglutide supplies due to quality isssue, shares hit

Dr. Reddy’s to delay semaglutide supplies due to quality isssue, shares hit

Dr. Reddy’s to delay semaglutide supplies due to quality issue, shares hit

Dr Reddy's shares slide 7% after delay in semaglutide supplies over quality concerns

Dr Reddy's delays Semaglutide supplies after API-related quality issue

Torrent Pharma recalls select batches of Semalix injection after Dr. Reddy's notice

DRL’s semaglutide supply hits a stumbling block, affects other companies too

Dr. Reddy’s halts semaglutide supplies on quality concerns, shares plunge, Torrent recalls product

Dr Reddy’s pauses weight loss drug on quality fears

Dr Reddy's shares crash 9% in 2 days; brokerages slash target prices after semaglutide supply disruption. What lies ahead?

Broker’s call: Dr Reddy’s Lab (Accumulate)